Ranyi Liu
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 6
- Cancer-related molecular mechanisms research 5
- Oncology top 10%
- Biomaterials top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 5
- Pharmaceutical Science top 10%
-
- Genital Health and Disease 8
-
- Virus-based gene therapy research 7
-
- Cancer Research and Treatments 7
-
- Genetic factors in colorectal cancer 6
- Co-authors
- Wenlin HuangJiangxue WuZhizhong PanXiaofang YingXiangqi MengYufang ZuoChangchuan PanHui Wang
- Cited by
- Cancer ResearchOncologyBiomaterials
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ranyi Liu
49 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 411
- Oncology 431
- Biomaterials 172
- Molecular Biology 767
- Pharmaceutical Science 52
Countries citing papers authored by Ranyi Liu
This map shows the geographic impact of Ranyi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranyi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranyi Liu more than expected).
Fields of papers citing papers by Ranyi Liu
This network shows the impact of papers produced by Ranyi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranyi Liu. The network helps show where Ranyi Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ranyi Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 11 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 19 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 12 | |
| 9 | 2020 | 26 | |
| 10 | 2020 | 67 | |
| 11 | 2020 | 30 | |
| 12 | 2019 | 54 | |
| 13 | 2018 | 23 | |
| 14 | 2018 | 10 | |
| 15 | 2013 | 103 | |
| 16 | 2010 | 20 | |
| 17 | 2009 | 19 | |
| 18 | 2008 | 10 | |
| 19 | 2005 | 27 | |
| 20 | Transfection of adenovirus-mediated neurotrophin-3 gene into schwann cells | 2004 | 2 |
About Ranyi Liu
Ranyi Liu is a scholar working on Cancer Research, Biotechnology and Oncology, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Genital Health and Disease (8 papers), Virus-based gene therapy research (7 papers), Cancer Research and Treatments (7 papers), RNA modifications and cancer (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Genetic factors in colorectal cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (411 citations), Oncology (431 citations) and Biomaterials (172 citations). Ranyi Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wenlin Huang, Jiangxue Wu, Zhizhong Pan, Xiaofang Ying, Xiangqi Meng, Yufang Zuo, Changchuan Pan, Hui Wang, Xiaowei Zeng and Lin Mei. Their work appears in journals such as Nature Communications, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.